$RPID Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.27
• Reported revenue of $8.05M up 10.91% YoY
• Rapid Micro Biosystems is reaffirming its full year 2026 total revenue guidance range of $37.0 million to $41.0 million, including 30 to 38 Growth Direct system placements and gross margins of 20%.